Shibata Fumi | Department Of Cellular Therapy Advanced Clinical Research Center University Of Tokyo
スポンサーリンク
概要
- SHIBATA Fumiの詳細を見る
- 同名の論文著者
- Department Of Cellular Therapy Advanced Clinical Research Center University Of Tokyoの論文著者
関連著者
-
Shibata Fumi
Department Of Cellular Therapy Advanced Clinical Research Center University Of Tokyo
-
KITAMURA Toshio
Department of Hematopoietic Factors, Institute of medical Science, University of Tokyo
-
Shimoda Kazuya
The First Department Of Internal Medicine Faculty Of Medicine Kyushu University
-
Miura Osamu
Department Of Hematology And Oncology Graduate School Of Medicine Tokyo Medical And Dental Universit
-
NAKAJIMA Hideaki
Center of Excellence, Institute of Medical Science, University of Tokyo
-
SHIBATA Fumi
Department of Cellular Therapy, Advanced Clinical Research Center, University of Tokyo
-
KUMAGAI Hidetoshi
Department of Cellular Therapy, Advanced Clinical Research Center, University of Tokyo
-
Yamamoto Koh
Department Of Hematology And Oncology Tokyo Medical And Dental University
-
Yamamoto Koh
Department Of Food Science And Technology Faculty Of Agriculture Kyushu University
-
Kumagai Hidetoshi
Department Of Cellular Therapy Advanced Clinical Research Center University Of Tokyo
-
Kitamura Toshio
Department Of Bioresources Chemistry Faculty Of Agriculture Okayama University
-
Kitamura Toshio
Department Of Cellular Therapy Advanced Clinical Research Center University Of Tokyo
-
Miura Osamu
Department Of Hematology And Oncology Tokyo Medical And Dental University
-
Nakajima Hideaki
Center Of Excellence Institute Of Medical Science University Of Tokyo
-
YAMAGUCHI Mitsuko
Department of Hematology and Oncology, Tokyo Medical and Dental University
-
Miura Osamu
Department Of Ecology And Evolutionary Biology Graduate School Of Life Sciences University Of Tohoku
-
Yamaguchi Mitsuko
Department Of Hematology And Oncology Tokyo Medical And Dental University
-
Shibata Fumi
Department Of Hematology And Oncology Tokyo Medical And Dental University
著作論文
- Tyk2 Is Dispensable for Induction of Myeloproliferative Disease by Mutant FLT3
- Fusion of MLL and MSF in Adult De Novo Acute Myelomonocytic Leukemia (M4) with t(11;17)(q23;q25)